| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer,Svp-r& D | Chief Scientific Officer,Svp-r& D | Sr Vp-research & Development +1 more
1 company
Frederique Ph.D. Menzaghi last filed a Form 4 in February 2024, as Chief Scientific Officer,Svp-r& D at TVRD. From March 2015 to February 2024, the filings on record show 0 open-market purchases and 45 sales. Frederique Ph.D. Menzaghi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Frederique Ph.D. Menzaghi a strong insider score of 85/100, based on 7 past trades. Over a 12-month horizon, all 7 of those trades were profitable, with an average 12-month return of +64.8%.
At the last filing, the largest reported position was 167,247 shares of TVRD. The TVRD filings lean toward selling, a net 283,239 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 3,000 | $15.49 | $46,470.00 | -2.7% | |
| May 23, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 9,000 | $15.19 | $136,710.00 | -7.6% | |
| Feb 15, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 3,000 | $15.02 | $45,060.00 | -2.5% | |
| Jan 24, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 15,000 | $15.00 | $225,000.00 | -10.9% | |
| Aug 4, 2017 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 3,000 | $15.00 | $45,000.00 | -2.5% | |
| Jul 14, 2017 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 3,000 | $15.00 | $45,000.00 | -2.4% | |
| Apr 20, 2016 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 6,000 | $9.00 | $54,000.00 | -4.7% | |
| Feb 3, 2016 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 6,000 | $9.04 | $54,250.00 | -4.4% | |
| Jan 4, 2016 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 6,000 | $16.80 | $100,800.00 | -4.3% | |
| Dec 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 6,000 | $16.21 | $97,260.00 | -4.1% |